18F-FLUDEOXYGLUCOSE (18F-FDG) 7400 MBq (Fludeoxyglucose 18f SOLUTION) 7400 MBq

18F-Fludeoxyglucose (18F-FDG) 7400 MBq is a radiopharmaceutical solution used in diagnostic imaging. This intravenous solution is manufactured by Isologic Innovative Radiopharmaceuticals Ltd. in Canada.

Strength

7400 MBq

Pack Size

30ML

Manufacturer / TM Owner

ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

18F-Fludeoxyglucose (18F-FDG) is primarily used in positron emission tomography (PET) scans to help visualize metabolic processes in the body. It is often utilized in the assessment of various conditions, including but not limited to, cancer, heart disease, and neurological disorders. The solution is administered intravenously and helps in identifying areas of high metabolic activity.

Side Effects

The effects of 18F-Fludeoxyglucose (18F-FDG) are primarily observed through imaging techniques. It is designed to be taken up by cells with high metabolic rates, which can then be detected using PET scans. This helps in providing detailed images that can aid in the evaluation of various medical conditions.

Precautions & Warnings

Handling 18F-Fludeoxyglucose (18F-FDG) requires strict adherence to safety protocols due to its radioactive nature. It should be used under the supervision of qualified healthcare professionals. Proper shielding and disposal methods must be followed to ensure safety.

Avoid Interactions

18F-Fludeoxyglucose (18F-FDG) may interact with certain medications and substances. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, before undergoing a PET scan. Alcohol and certain foods may also affect the accuracy of the scan results.

Frequently Asked Questions

18F-Fludeoxyglucose (18F-FDG) is used in PET scans to help visualize metabolic processes in the body, aiding in the assessment of conditions like cancer, heart disease, and neurological disorders.

18F-Fludeoxyglucose (18F-FDG) is administered intravenously by healthcare professionals in a controlled medical setting.

The effects are primarily observed through PET scans, where it helps in identifying areas of high metabolic activity in the body.

Yes, due to its radioactive nature, it should be handled with care and under the supervision of qualified healthcare professionals.

Yes, it may interact with certain medications and substances, so it is important to inform healthcare providers about all current medications before undergoing a PET scan.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.